Please login to the form below

Not currently logged in
Email:
Password:

Kiadis Pharma appoints new chief operations officer

Jan Feijen joins the company from Janssen

Dutch company Kiadis Pharma has appointed Jan Feijen as its new chief operations officer with responsibility for manufacturing, supply chain, QA and project management.

Feijen arrives at Kiadis Pharma from Janssen where he was vice president manufacturing and technical operations, platform lead vaccines and advanced therapies.

He said: “I am very pleased to be joining Kiadis Pharma at this important time in its development. With the company’s pivotal phase III trial with ATIR101 now underway, it is vital that the necessary steps are taken to ensure everything continues to run smoothly and that we have all logistics in hand ready to roll out commercially in the future.”

Prior to his time at Janssen, Feijen held positions for the likes of Crucell, Avebe and Gist Brocades.

Arthur Lahr, CEO at Kiadis Pharma, said: “We are very pleased that an industry leader like Jan has accepted this opportunity to join Kiadis Pharma. His vast experience in pharma production precedes him, and his experience in running complex, just-in-time logistics will be of great value in scaling up our patient specific supply chain.”

21st March 2017

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Flu
Influenza – the risk to vulnerable populations
Why we can't get complacent about flu vaccination...
dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...
Data security
Concerns about data security are building a strong case for clinical mobility in EMEA
Electronic medical records have transformed the storage of sensitive information but how can the healthcare sector continue to protect patient and staff data?...